🇺🇸 FDA
Patent

US 9622991

Hematopoietic growth factor mimetic small molecule compounds and their uses

granted A61KA61K31/15A61K31/167

Quick answer

US patent 9622991 (Hematopoietic growth factor mimetic small molecule compounds and their uses) held by Ligand Pharmaceuticals Incorporated expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/15, A61K31/167, A61K31/18, A61K31/245